Publicaciones relevantes
1. Sawka AM, Ghai S, Rotstein L, Irish JC, Pasternak JD, Monteiro E, Chung J, Su J,
Xu W, Esemezie AO, Jones JM, Gafni A, Baxter NN, Goldstein DP, Canadian Thyroid
Cancer Active Surveillance Study Group (Greater Toronto Area). Long-Term Durability
of Active Surveillance of Small, Low-Risk Papillary Thyroid Cancer. JAMA Surg. 2025
Aug 20. Coauthor or Collaborator.
2. Noltes ME, Cottrell J, Madani A, Rotstein L, Gomez-Hernandez K, Devon K,
Boggild MK, Goldstein DP, Wong EM, Brouwers AH, Kruijff S, Eskander A, Monteiro E,
Pasternak JD. Quality Indicators for the Diagnosis and Management of Primary
Hyperparathyroidism. JAMA Otolaryngol Heald Neck Surg. 2022 Mar 1;3(148):209-219.
Coauthor or Collaborator.
3. Lukovic J, Petrovic I, Liu Z, Armstrong SM, Brierley JD, Tsang R, Pasternak JD,
Gomez-Hernandez K, Liu A, Asa SL, Mete O. Oncocytic Papillary Thyroid Carcinoma
and Oncocytic Poorly Differentiated Thyroid Carcinoma: Clinical Features, Uptake,
and Response to Radioactive Iodine Therapy, and Outcome. Front Endocrinol
(Lausanne). 2021 Dec 16;12(795184). Coauthor or Collaborator.
4. Salama Y, Albanyan S, Szybowska M, Bullivant G, Gallinger B, Giles RH, Asa S,
Badduke C, Chiorean A, Druker H, Ezzat S, Hannah-Shmouni F, Hernandez KG, Inglese
C, Jani P, Kaur Y, Krema H, Krimus L, Laperriere N, Lichner Z, Mete O, Sit M, Zadeh G,
Jewett MAS, Malkin D, Stockley T, Wasserman JD, Xu W, Schachter NF, Kim RH.
Comprehensive characterization of a Canadian cohort of von Hippel-Lindau disease
patients. Clin Genet. 2019 Nov;96(5):451-457. Available from:
https://www.ncbi.nlm.nih.gov/pubmed/31368132. Coauthor or Collaborator.
5. Mete O, Gomez-Hernandez K, Kucharczyk W, Ridout R, Zadeh G, Gentili F, Ezzat
S, Asa S. Silent subtype 3 pituitary adenomas are not always silent and represent
poorly differentiated monomorphous plurihormonal Pit-1 lineage adenomas. Modern
Pathology. 2016;29:131-42. Co-Principal Author.
6. Duan K, Gomez Hernandez K, Mete O. Clinicopathological correlates of
hyperparathyroidism. J Clin Pathol. 2015 Jul 10. pii: jclinpath-2015-203186.
doi:10.1136/jclinpath-2015-203186. [Epub ahead of print]. Coauthor or Collaborator.
7. Cheng S, Gomez K, Serri O, Chik C, Ezzat S. The role of diabetes in acromegaly
associated neoplasia. PLoS One. 2015;10(5):e0127276. Coauthor or Collaborator.
8. Gomez Hernandez K, Ezzat S, Asa SL, Mete O. Clinical implications of accurate
subtyping of pituitary adenomas: Perspective from treating physician. Turk Patoloji
Derg. 2015;31(Suppl 1):4-17. Principal Author.
9. Duan K, Gomez Hernandez K, Mete O. Clinicopathological correlates of
adrenal Cushing’s syndrome. Postgrad Med J. 2015;91(1076):331-342. Coauthor or
Collaborator.
10. Agrawal N, Akbani R, Aksoy B, Ally A, Arachchi H, Asa SL, Auman JT,
Balasundaram M, Balu S, Baylin SB, Behera M, Bernard B, Beroukhim R, Bishop JA,
Black AD, Bodenheimer T, Boice L, Bootwalla MS, Bowen J, Bowlby R, Bristow CA,
Brookens R, Brooks D, Bryant R, Buda E, Butterfield V, Carling T, Carlsen R, Carter SL,
SE Carty, TA Chan, AY Chen, AD Cherniack, DC, L Chin, Cho, A Chu, E Chuah,
Cibulskis V, Ciriello V, Clarke A, Clayman GL, Cope L, Copland JA, Covington K,
Danilova L, Davidsen T, Demchok JA, DiCara D, Dhalla N, Dhir R, Dookran SS,
Dresdner G, Eldridge J, Eley G, El-Naggar A, Eng S, Fagin JA, Fennell T, Ferris RL, Fisher
S, Frazer S, Frick J, Gabriel SB, Ganly I, Gao J, Garraway LA, Gastier-Foster JM, Getz G,
borg N G, Ghossein R, Gibbs RA, Giordano TJ, Gomez-Hernandez K, et al. Integrated
genomic characterization of papillary thyroid carcinoma. Cell. 2014;159:676-90.
11. Duan K, Gomez Hernandez K, Mete O. Clinicopathological correlates of
adrenal Cushing’s syndrome. J Clin Pathol. 2014:2014-202612.
12. Yip J, Orlov S, Orlov D, Vaisman A, Hernandez KG, Etarsky D, Kak I, Parvinnejad
N, Freeman JL, Walfish PG. Predictive value of metastatic cervical lymph node ratio in
papillary thyroid carcinoma recurrence. Head Neck. 2013;35:592-8.
13. Gomez K. Varghese J, Jimenez C. Medullary Thyroid Carcinoma: Molecular
Signaling Pathways and Emerging Therapies. J Thyroid Res. 2011:815826.
14. Gomez Hernandez K, Chen-Ku CH. Hiperaldosteronismo primario. Acta Médica
Costarricense. 2007;49:13-20.
15. Khan A, Kenshole A, Ezzat S, Goguen J, Gomez-Hernandez K, Hegele RA,
Houlden R, Joy T, Keely E, Killinger D, Lacroix A, Laredo S, Prebtani APH, Shrayyef MZ,
Tran C, Van Uum S, Reardon R, Papageorgiou A, Tays W, Edmonds M. Tools for
Enhancement and Quality Improvement of Peer Assessment and Clinical Care in Endocrinology and Metabolism. J Clin Densitom. 2017 Jul 21. Coauthor or
Collaborator.
Capítulos en Libros
1. Gomez Hernandez K, Ezzat S. Clinical Manifestations of Endocrine Diseases.
In: Mete O, Asa SL, editor(s). Endocrine Pathology. (United Kingdom): Cambridge
University Press; 2016. ISBN: 9781107443310.
2. Tateno T, Gomez Hernandez K, Asa SL, Ezzat S. Epigenetics and pituitary cell
growth. In: Ulloa-Aguirre A, Conn M, editor(s). Cellular Endocrinology in Health and
Disease. 1st ed. Elsevier; 2014. p. 101-110.
Editoriales
1. Gomez Hernandez K, Ezzat S. Lessons learned from thyroglobulin
concentrations after total thyroidectomy and radioactive iodine ablation for
differentiated thyroid cancer. Clin Biochem. 2015;48:747-8.
Cartas al Editor
1. Gomez Hernandez K, Etarsky D, Orlov S, Walfish PG. Stimulated thyroglobulin
and neck ultrasonography facilitates postsurgical radioactive
